1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Transforming Growth Factor-β: Master Regulator of the Respiratory System in Health and Disease

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In this article, we review the biology and physiological importance of transforming growth factor-β (TGF-β) to homeostasis in the respiratory system, its importance to innate and adaptive immune responses in the lung, and its pathophysiological role in various chronic pulmonary diseases including pulmonary arterial hypertension, chronic obstructive pulmonary disease, asthma, and pulmonary fibrosis. The TGF-β family is responsible for initiation of the intracellular signaling pathways that direct numerous cellular activities including proliferation, differentiation, extracellular matrix synthesis, and apoptosis. When TGF-β signaling is dysregulated or essential control mechanisms are unbalanced, the consequences of organ and tissue dysfunction can be profound. The complexities and myriad checkpoints built into the TGF-β signaling pathways provide attractive targets for the treatment of these disease states, many of which are currently being investigated. This review focuses on those aspects of TGF-β biology that are most relevant to pulmonary diseases and that hold promise as novel therapeutic targets.

          Related collections

          Author and article information

          Journal
          Am J Respir Cell Mol Biol
          Am. J. Respir. Cell Mol. Biol
          ajrcmb
          American Journal of Respiratory Cell and Molecular Biology
          American Thoracic Society
          1044-1549
          1535-4989
          May 2016
          May 2016
          : 54
          : 5
          : 647-655
          Affiliations
          [ 1 ]Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, and
          [ 2 ]Department of Immunology and Microbiology, University of Colorado, Aurora, Colorado; and
          [ 3 ]Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, and
          [ 4 ]Departments of Pediatrics, and
          [ 5 ]Biomedical Research, National Jewish Health, Denver, Colorado
          Author notes
          Correspondence and requests for reprints should be addressed to Yael Aschner, M.D., Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, RC2 Room 9261, 12700 East 19th Avenue, University of Colorado Anschutz Medical Campus, Aurora, CO 80045. E-mail: yael.aschner@ 123456ucdenver.edu .
          Article
          PMC4942197 PMC4942197 4942197 2015-0391TR
          10.1165/rcmb.2015-0391TR
          4942197
          26796672
          40d3cc19-1d3c-4445-a42a-84a54d3d9b63
          Copyright © 2016 by the American Thoracic Society
          History
          : 11 December 2015
          : 18 January 2016
          Page count
          Figures: 2, Tables: 0, Pages: 9
          Categories
          Translational Review

          fibroblast,pulmonary arterial hypertension,asthma,COPD,pulmonary fibrosis

          Comments

          Comment on this article